Company profile

Ticker
BIO.B
Exchange
Website
CEO
Norman D. Schwartz
Employees
Incorporated in
Location
Fiscal year end
Former names
Bio Rad Laboratories Inc
SEC CIK
IRS number
941381833

BIO.B stock data

(
)
FINRA relative short interest over last month (8 trading days) ?

Calendar

2 Mar 20
6 Apr 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 624.5M 560.6M 572.6M 554M
Net income 553.5M -258.8M 598.8M 865.2M
Diluted EPS 18.31 -8.68 19.86 28.74
Net profit margin 88.63% -46.16% 105% 156%
Operating income 59.21M 57.46M 56.39M 56.61M
Net change in cash 99.6M -19.61M 124.79M 24.36M
Cash on hand 660.67M 561.07M 580.68M 455.89M
Cost of revenue 293.99M 253.61M 264.85M 242.22M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 2.31B 2.29B 2.16B 2.07B
Net income 1.76B 365.61M 122.25M 26M
Diluted EPS 58.27 12.1 4.07 0.88
Net profit margin 76.08% 15.97% 5.66% 1.26%
Operating income 229.66M -103.34M 119.25M 55.72M
Net change in cash 229.15M 47.7M -72.44M -1.29M
Cash on hand 660.67M 431.53M 383.82M 456.26M
Cost of revenue 1.05B 1.07B 972.45M 929.74M

Financial data from company earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
16 Dec 19 Dara Wright NQSO Bio-Rad A Common Stock Grant Aquire A 366.89 2,511 921.26K 2,511
16 Dec 19 Dara Wright RSU Bio-Rad A Common Stock Grant Aquire A 0 2,511 0 2,511
4 Dec 19 Timothy S Ernst Bio-Rad A Common Stock Sell Dispose S 370.12 656 242.8K 455.704
4 Dec 19 Timothy S Ernst Bio-Rad A Common Stock Sell Dispose S 370.11 1,250 462.64K 1,111.704
4 Dec 19 Timothy S Ernst Bio-Rad A Common Stock Option exercise Aquire M 159.32 1,250 199.15K 2,361.704
4 Dec 19 Timothy S Ernst NQSO Bio-Rad A Common Stock Option exercise Dispose M 159.32 1,250 199.15K 1,250
3 Dec 19 Steven D Schwartz Bio-Rad B Common Stock Gift Aquire G 0 40 0 12,811
3 Dec 19 Steven D Schwartz Bio-Rad B Common Stock Gift Aquire G 0 40 0 25,039
75.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 382 355 +7.6%
Opened positions 78 56 +39.3%
Closed positions 51 28 +82.1%
Increased positions 136 146 -6.8%
Reduced positions 111 96 +15.6%
13F shares
Current Prev Q Change
Total value 6.98B 6.32B +10.4%
Total shares 18.86M 19M -0.8%
Total puts 23.8K 82.9K -71.3%
Total calls 70.8K 24.7K +186.6%
Total put/call ratio 0.3 3.4 -90.0%
Largest owners
Shares Value Change
BLK BlackRock 2.32M $858.12M +10.5%
Vanguard 1.98M $731.75M +2.8%
Atlanta Capital Management Co L L C 749.83K $277.46M -0.5%
American Century Companies 718.65K $265.92M -1.2%
STT State Street 656.85K $243.06M +31.1%
FMR 644.08K $238.33M +30.3%
WFC Wells Fargo & Co. 519.9K $192.38M -22.6%
Westfield Capital Management 460.63K $170.45M +11.8%
Ubs Global Asset Management Americas 441.34K $163.31M +5.5%
Alliancebernstein 378.33K $140M +2.8%
Largest transactions
Shares Bought/sold Change
Acadian Asset Management 0 -370.55K EXIT
Brown Advisory 228.51K +228.51K NEW
BLK BlackRock 2.32M +219.94K +10.5%
Norges Bank 211.27K +211.27K NEW
Millennium Management 268.98K -202.38K -42.9%
STT State Street 656.85K +156K +31.1%
WFC Wells Fargo & Co. 519.9K -151.45K -22.6%
FMR 644.08K +149.84K +30.3%
Aqr Capital Management 319.84K +137.36K +75.3%
Manufacturers Life Insurance Company, The 36.26K -119.12K -76.7%

Financial report summary

?
Risks
  • Our international operations expose us to additional costs and legal and regulatory risks, which could have a material adverse effect on our business, results of operations and financial condition.
  • The industries and market segments in which we operate are highly competitive, and we may not be able to compete effectively.
  • We may not be able to grow our business because of our failure to develop new or improved products.
  • Breaches of our information systems could have a material adverse effect on our business and results of operations.
  • If our information technology systems are disrupted, or if we fail to successfully implement, manage and integrate our information technology and reporting systems, our business, results of operations and financial condition could be harmed.
  • We are subject to foreign currency exchange fluctuations, which could have a material adverse effect on our results of operations and financial condition.
  • Our reported financial results may be materially affected by changes in the market value of our investment in Sartorius AG.
  • We may incur losses in future periods due to write-downs in the value of financial instruments.
  • We may experience difficulties implementing our new global enterprise resource planning system.
  • Recent and planned changes to our organizational structure and executive management team could negatively impact our business.
  • Violations of the U.S. Foreign Corrupt Practices Act or similar anti-corruption laws could have a material adverse effect on our business, results of operations and financial condition.
  • Our failure to establish and maintain effective internal control over financial reporting could result in material misstatements in our financial statements, our failure to meet our reporting obligations and cause investors to lose confidence in our reported financial information, which in turn could cause the trading price of our common stock to decline.
  • Risks relating to intellectual property rights may negatively impact our business.
  • Global economic and geopolitical conditions could adversely affect our operations.
  • Reductions in government funding and the capital spending programs of our customers could have a material adverse effect on our business, results of operations or financial condition.
  • Changes in the healthcare industry could have an adverse effect on our business, results of operations and financial condition.
  • We are subject to substantial government regulation, and any changes in regulation or violations of regulations by us could adversely affect our business, prospects, results of operations or financial condition.
  • We cannot assure you that we will be able to integrate acquired companies, products or technologies into our company successfully, or we may not be able to realize the anticipated benefits from the acquisitions.
  • Product quality and liability issues could harm our reputation and negatively impact our business, results of operations and financial condition.
  • Lack of key personnel could hurt our business.
  • A reduction or interruption in the supply of components and raw materials could adversely affect our manufacturing operations and related product sales.
  • Natural disasters, terrorist attacks, acts of war or other events beyond our control may cause damage or disruption to us and our employees, facilities, information systems, security systems, vendors and customers, which could significantly impact our business, results of operations and financial condition.
  • We may have higher than anticipated tax liabilities.
  • Changes in tax laws or rates, changes in the interpretation of tax laws or changes in the jurisdictional mix of our earnings could adversely affect our financial position and results of operations.
  • Our reported financial results may be materially affected by changes in accounting principles generally accepted in the United States.
  • Environmental, health and safety regulations and enforcement proceedings may negatively impact our business, results of operations and financial condition.
  • Our debt may restrict our future operations.
  • We are subject to healthcare laws and regulations and could face substantial penalties if we are unable to fully comply with such laws.
  • Regulations related to “conflict minerals” could adversely impact our business.
  • A significant majority of our voting stock is held by the Schwartz family, which could lead to conflicts of interest.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: absorption, Andrew, ascertain, assay, attack, BIOb, Canada, cited, Citibank, comparison, cyber, cyberattack, Daskal, degrade, disable, dispute, earliest, endorsed, escrow, Exact, geopolitical, heavily, Hertia, Ilan, implicit, inception, incident, innovation, John, Joint, layered, led, LLC, membership, Mexican, Mexico, misuse, MUFG, noncancellable, offline, online, outbreak, predominantly, Proforma, PST, ransom, rare, receipt, reissued, reissuing, repayment, repurposed, ROU, sabotage, SAP, Satisfaction, Simplification, uncommon, unrelated, verification
Removed: accelerated, acid, actively, agreed, antibody, bearing, biopsy, cancer, check, Christine, combined, continuing, cooperation, decreasing, deduction, delinquent, deposit, disgorgement, eliminated, employer, enabling, entity, exceeded, excise, expired, expression, filer, forfeiture, foundational, gene, genetic, genomic, GnuBIO, implemented, implied, improving, informed, inherited, investigate, Latin, mark, marketability, monitoring, moratorium, par, phase, preceding, preferred, priced, Pub, RainDance, reclassify, reversal, revised, scope, seasoned, sequencing, shell, spend, step, submitted, terminal, traded, updated, virtue, Washington